| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Atenolol measurement |
Component |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol poisoning |
Causative agent (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental atenolol poisoning |
Causative agent (attribute) |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional atenolol poisoning |
Causative agent (attribute) |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| intoxication par l'aténolol d'intention indéterminée |
Causative agent (attribute) |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol adverse reaction |
Causative agent (attribute) |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Atenolol overdose (disorder) |
Causative agent (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental atenolol overdose |
Causative agent (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Intentional atenolol overdose |
Causative agent (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| surdose d'aténolol d'intention indéterminée |
Causative agent (attribute) |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely atenolol 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Atenolol 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely atenolol 25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Atenolol 25mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Atenolol 5mg/10mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Atenolol 50 mg and chlortalidone 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Co-tenidone 100mg/25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Atenolol+nifedipine 50mg/20mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Atenolol+calcium channel blocker |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Atenolol+diuretic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Co-tenidone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing atenolol and bendroflumethiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing amiloride and atenolol and hydrochlorothiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Atenolol + chlorthalidone 100mg/25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Atenolol 50 mg and chlortalidone 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing atenolol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol- and nifedipine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing atenolol and chlortalidone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Accidental atenolol poisoning |
Causative agent (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Intentional atenolol poisoning |
Causative agent (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to atenolol (finding) |
Causative agent (attribute) |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Atenolol adverse reaction (disorder) |
Causative agent (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol sensitivity |
Causative agent (attribute) |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing atenolol in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to atenolol (finding) |
Causative agent (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely atenolol 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely atenolol 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol 100 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely atenolol 25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely atenolol 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule |
Has basis of strength substance (attribute) |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Atenolol 50 mg and chlortalidone 12.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has basis of strength substance (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol 50 mg and chlortalidone 25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Atenolol 50 mg and chlortalidone 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol 50 mg and chlortalidone 12.5 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol + chlorthalidone 100mg/25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Atenolol + chlorthalidone 100mg/25mg tablet |
Has basis of strength substance (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Atenolol 50 mg and chlortalidone 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol 50 mg and chlortalidone 25 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol 50 mg and nifedipine 20 mg prolonged-release oral capsule |
Has basis of strength substance (attribute) |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol 50 mg and nifedipine 20 mg prolonged-release oral capsule |
Has precise active ingredient |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely atenolol 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely atenolol 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Amiloride- and atenolol- and hydrochlorothiazide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Atenolol- and bendroflumethiazide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol- and chlortalidone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Atenolol 50 mg and chlortalidone 25 mg oral tablet |
Has precise active ingredient |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Atenolol 100 mg oral tablet |
Has precise active ingredient |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has precise active ingredient |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule |
Has precise active ingredient |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol 50 mg and chlortalidone 12.5 mg oral tablet |
Has precise active ingredient |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Atenolol + chlorthalidone 100mg/25mg tablet |
Has precise active ingredient |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Atenolol 5 mg/mL oral solution |
Has precise active ingredient |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol 5 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely atenolol 5 milligram/10 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely atenolol 5 milligram/10 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing atenolol and nifedipine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only amiloride and atenolol and hydrochlorothiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Atenolol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only atenolol and nifedipine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only atenolol and bendroflumethiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol and chlortalidone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only amiloride and atenolol and hydrochlorothiazide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Atenolol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only atenolol and bendroflumethiazide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only atenolol and chlortalidone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Atenolol and nifedipine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only atenolol in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol 500 microgram/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol 500 microgram/mL solution for injection |
Has precise active ingredient |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atenolol 50 mg and nifedipine 20 mg prolonged-release oral capsule |
Has basis of strength substance (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Atenolol 50 mg and nifedipine 20 mg prolonged-release oral capsule |
Has precise active ingredient |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Amlodipine- and atenolol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing amlodipine and atenolol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only amlodipine and atenolol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only amlodipine and atenolol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and atenolol 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and atenolol 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely atenolol 50 milligram and levamlodipine (as levamlodipine besilate) 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely atenolol 50 milligram and levamlodipine (as levamlodipine besilate) 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Atenolol and levamlodipine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Atenolol- and levamlodipine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only atenolol and levamlodipine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]